Tech Company Financing Transactions
Zebra Biologics Funding Round
Zebra Biologics closed a $3 million financing round on 12/3/2015. Investors included private investors.
Transaction Overview
Company Name
Announced On
12/3/2015
Transaction Type
Venture Equity
Amount
$3,000,060
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1041 Old Marlboro Rd.
Concord, MA 01742
USA
Concord, MA 01742
USA
Phone
Website
Email Address
Overview
Zebra Biologics Inc. is a start-up biotechnology company focused on a next-gen approach to more efficiently and more effectively discovering and developing novel human biologic drugs utilizing a proprietary platform technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ronald Lindsay
Chief Scientific Officer
Peter DiStefano
Browse more venture capital transactions:
Prev: 12/3/2015: Contessa Health venture capital transaction
Next: 12/3/2015: younity venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs